Class information for:
Level 1: HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
20943 379 40.5 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
495 14696 RADIATION RESEARCH//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//AMIFOSTINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HUMAN MALIGNANT GLIOMAS Author keyword 4 75% 1% 3
2 MOL EXPT RADIOL Address 3 38% 2% 6
3 RADGENOM GRP Address 1 31% 1% 4
4 EYEWITNESS ACCOUNT Author keyword 1 50% 1% 2
5 INSERM U908 Address 1 50% 1% 2
6 NEUROFORENSIC ANALYSIS Author keyword 1 100% 1% 2
7 RADIAT PROTECT DOSIMETRY CALIBRAT EXPERT GRP Address 1 100% 1% 2
8 HEAVY ION RADIOBIOL THER Y Address 1 40% 1% 2
9 ONCORAY RADIAT Address 1 33% 1% 2
10 AKT PKB ACTIVATION Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 HUMAN MALIGNANT GLIOMAS 4 75% 1% 3 Search HUMAN+MALIGNANT+GLIOMAS Search HUMAN+MALIGNANT+GLIOMAS
2 EYEWITNESS ACCOUNT 1 50% 1% 2 Search EYEWITNESS+ACCOUNT Search EYEWITNESS+ACCOUNT
3 NEUROFORENSIC ANALYSIS 1 100% 1% 2 Search NEUROFORENSIC+ANALYSIS Search NEUROFORENSIC+ANALYSIS
4 AKT PKB ACTIVATION 1 50% 0% 1 Search AKT+PKB+ACTIVATION Search AKT+PKB+ACTIVATION
5 CANCER CELL INFILTRATION 1 50% 0% 1 Search CANCER+CELL+INFILTRATION Search CANCER+CELL+INFILTRATION
6 CANCER DERIVED ENDOTHELIAL CELLS 1 50% 0% 1 Search CANCER+DERIVED+ENDOTHELIAL+CELLS Search CANCER+DERIVED+ENDOTHELIAL+CELLS
7 CAPILLARY LIKE STRUCTURE FORMATION 1 50% 0% 1 Search CAPILLARY+LIKE+STRUCTURE+FORMATION Search CAPILLARY+LIKE+STRUCTURE+FORMATION
8 HIF I ALPHA 1 50% 0% 1 Search HIF+I+ALPHA Search HIF+I+ALPHA
9 JEJUNUM CRYPT 1 50% 0% 1 Search JEJUNUM+CRYPT Search JEJUNUM+CRYPT
10 MATRIX METALLOPROTEINASE II 1 50% 0% 1 Search MATRIX+METALLOPROTEINASE+II Search MATRIX+METALLOPROTEINASE+II

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 STROMAL SENSITIVITY 4 75% 1% 3
2 RADIATION INDUCED INCREASE 3 45% 1% 5
3 VEGFR2 BLOCKADE 2 44% 1% 4
4 RELEVANT TREATMENT CONDITIONS 2 67% 1% 2
5 TUMOR RADIATION RESPONSE 2 36% 1% 4
6 RHOB 1 21% 2% 6
7 FACTOR NEUTRALIZING ANTIBODY 1 27% 1% 4
8 INCREASED METASTATIC DISSEMINATION 1 33% 1% 2
9 PERMANENT IMPLANTATION 1 33% 1% 2
10 2 MURINE TUMORS 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Radiation-enhanced cell migration/invasion process: A review 2014 4 54 52%
Current status of angiogenesis inhibitors combined with radiation therapy 2006 73 94 27%
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy 2010 90 135 11%
Effects of irradiation on tumor cell survival, invasion and angiogenesis 2010 25 138 25%
Does ionizing radiation stimulate cancer invasion and metastasis? 2008 40 47 19%
Radiobiology dedicated to endothelium 2012 5 38 26%
Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy 2011 11 80 21%
Combining angiogenesis inhibition and radiotherapy: A double-edged sword 2012 13 86 15%
Design of clinical trials of radiation combined with antiangiogenic therapy 2007 54 97 14%
Antiangiogenics: The potential role of integrating this novel treatment modality with chemoradiation for solid cancers 2007 77 55 11%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MOL EXPT RADIOL 3 38% 1.6% 6
2 RADGENOM GRP 1 31% 1.1% 4
3 INSERM U908 1 50% 0.5% 2
4 RADIAT PROTECT DOSIMETRY CALIBRAT EXPERT GRP 1 100% 0.5% 2
5 HEAVY ION RADIOBIOL THER Y 1 40% 0.5% 2
6 ONCORAY RADIAT 1 33% 0.5% 2
7 EA2710 1 50% 0.3% 1
8 KKG INNATE IMMUN TUMOR BIOL 1 50% 0.3% 1
9 RADGEN GRP 1 50% 0.3% 1
10 TRANSDISCIPLINARY LIFE SCI COURSE 1 19% 0.8% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000248630 TCD50//REPOPULATION//R1H RHABDOMYOSARCOMA
2 0.0000199483 MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING
3 0.0000196678 BIOMARKERS BRANCH//CLONOGEN//COLORADO PARTY
4 0.0000125860 RECOMBINANT VACCINE GRP//ABSCOPAL EFFECT//IMMUNOGENIC TUMOR CELL DEATH
5 0.0000121160 NIMOTUZUMAB//H R3//CETUXIMAB
6 0.0000113195 MGDC//VERRUCARIN A//RADIAT TUMOR PHYSIOL
7 0.0000111149 EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS
8 0.0000110906 INTERSTITIAL FLUID PRESSURE//EDWIN L STEELE//CANCER DETECTION AND TREATMENT
9 0.0000099985 NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY
10 0.0000085633 GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL